Role of serotonin2C receptors in the control of brain dopaminergic function

被引:125
作者
Di Matteo, V
Cacchio, M
Di Giulio, C
Esposito, E [1 ]
机构
[1] Ist Ric Farmacol Mario Negri, Consorzio Mario Negri Sud, I-66030 Santa Maria Imbaro, Chieti, Italy
[2] Univ G DAnnunzio, Dept Biomed Sci, Chieti, Italy
关键词
5-HT2C receptors; dopaminergic function; mesolimbic system; nigrostriatal system; antidepressants; antipsychotics;
D O I
10.1016/S0091-3057(01)00705-5
中图分类号
B84 [心理学]; C [社会科学总论]; Q98 [人类学];
学科分类号
03 ; 0303 ; 030303 ; 04 ; 0402 ;
摘要
There is substantial evidence that the functional status of mesocorticolimbic dopaminergic (DA) system originating in the ventral tegmental area (VTA) is under a phasic and tonic inhibitory control by the serotonergic system, which acts by stimulating serotonin(2C) (5-HT2C) receptor subtypes. This assertion is based upon a number of electrophysiological and biochemical data showing that 5-HT2C receptor agonists decrease, while 5-HT2C receptor antagonists enhance mesocorticolimbic DA function. On the other hand, it does not seem that 5-HT2C receptors play a relevant role in the control of nigrostriatal DA system originating in the substantia nigra pars compacta (SNc). The authors of this article review the most relevant data regarding the role of 5-HT2C receptors in the control of brain DA function and underline the importance of this subject in the search of new therapies for neuropsychiatric disorders such as depression, schizophrenia, drug addiction, and Parkinson's disease. (C) 2002 Elsevier Science Inc. All rights reserved.
引用
收藏
页码:727 / 734
页数:8
相关论文
共 52 条
[1]   Localization of the 5-hydroxytryptamine(2C) receptor protein in human and rat brain using specific antisera [J].
Abramowski, D ;
Rigo, M ;
Duc, D ;
Hoyer, D ;
Staufenbiel, M .
NEUROPHARMACOLOGY, 1995, 34 (12) :1635-1645
[2]   Levodopa - Is toxicity a myth? [J].
Agid, Y .
NEUROLOGY, 1998, 50 (04) :858-863
[3]   THE FUNCTIONAL-ANATOMY OF BASAL GANGLIA DISORDERS [J].
ALBIN, RL ;
YOUNG, AB ;
PENNEY, JB .
TRENDS IN NEUROSCIENCES, 1989, 12 (10) :366-375
[4]   AUTORADIOGRAPHIC ANALYSIS OF DIFFERENTIAL ASCENDING PROJECTIONS OF DORSAL AND MEDIAN RAPHE NUCLEI IN RAT [J].
AZMITIA, EC ;
SEGAL, M .
JOURNAL OF COMPARATIVE NEUROLOGY, 1978, 179 (03) :641-667
[5]   A review of central 5-HT receptors and their function [J].
Barnes, NM ;
Sharp, T .
NEUROPHARMACOLOGY, 1999, 38 (08) :1083-1152
[6]   5-HT2 RECEPTOR SUBTYPES - A FAMILY RE-UNITED [J].
BAXTER, G ;
KENNETT, G ;
BLANEY, F ;
BLACKBURN, T .
TRENDS IN PHARMACOLOGICAL SCIENCES, 1995, 16 (03) :105-110
[7]   MOLECULAR-BIOLOGY OF 5-HT RECEPTORS [J].
BOESS, FG ;
MARTIN, IL .
NEUROPHARMACOLOGY, 1994, 33 (3-4) :275-317
[8]   DOPAMINE AND DEPRESSION [J].
BROWN, AS ;
GERSHON, S .
JOURNAL OF NEURAL TRANSMISSION-GENERAL SECTION, 1993, 91 (2-3) :75-109
[9]   REPEATED TREATMENT WITH IMIPRAMINE AND AMITRIPTYLINE REDUCED THE IMMOBILITY OF RATS IN THE SWIMMING TEST BY ENHANCING DOPAMINE MECHANISMS IN THE NUCLEUS ACCUMBENS [J].
CERVO, L ;
SAMANIN, R .
JOURNAL OF PHARMACY AND PHARMACOLOGY, 1988, 40 (02) :155-156
[10]   MECHANISMS OF ACTION OF ATYPICAL ANTIPSYCHOTIC-DRUGS - IMPLICATIONS FOR NOVEL THERAPEUTIC STRATEGIES FOR SCHIZOPHRENIA [J].
DEUTCH, AY ;
MOGHADDAM, B ;
INNIS, RB ;
KRYSTAL, JH ;
AGHAJANIAN, GK ;
BUNNEY, BS ;
CHARNEY, DS .
SCHIZOPHRENIA RESEARCH, 1991, 4 (02) :121-156